Azilsartan Medoxomil (Edarbi)

Medical News: New ARB Cleared for Hypertension Treatment – in Cardiovascular, Hypertension from MedPage Today

The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.

TAK-491 would have been a better brand name IMHO.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s